(i) stimulating a T cell(ii) inhibiting signalling via PI3K alpha or PI3K delta or m-TOR or Akt in said T cell, wherein said inhibition is commenced 10 to 22 hours after the stimulation of (i). The invention also relates to certain uses of PI3K inhibitors, PI3K inhibitors for particular uses, and kits."/> USE OF PI3K M-TOR AND AKT INHIBITORS TO INDUCE FOXP3 EXPRESSION AND GENERATE REGULATORY T CELLS
首页> 外国专利> USE OF PI3K M-TOR AND AKT INHIBITORS TO INDUCE FOXP3 EXPRESSION AND GENERATE REGULATORY T CELLS

USE OF PI3K M-TOR AND AKT INHIBITORS TO INDUCE FOXP3 EXPRESSION AND GENERATE REGULATORY T CELLS

机译:使用PI3K M-TOR和AKT抑制剂诱导FOXP3表达并产生调控性T细胞

摘要

The invention relates to a method of inducing Foxp3 expression in a T cell comprising(i) stimulating a T cell(ii) inhibiting signalling via PI3K alpha or PI3K delta or m-TOR or Akt in said T cell, wherein said inhibition is commenced 10 to 22 hours after the stimulation of (i). The invention also relates to certain uses of PI3K inhibitors, PI3K inhibitors for particular uses, and kits.
机译:本发明涉及在T细胞中诱导Foxp3表达的方法,包括 (i)刺激T细胞 (ii)抑制经由PI3K alpha或PI3K delta或m-TOR或Akt的信号传导所述T细胞,其中所述抑制在(i)的刺激后10至22小时开始。本发明还涉及PI3K抑制剂的某些用途,用于特定用途的PI3K抑制剂和试剂盒。

著录项

  • 公开/公告号US2015147304A1

    专利类型

  • 公开/公告日2015-05-28

    原文格式PDF

  • 申请/专利权人 MEDICAL RESEARCH COUNCIL;

    申请/专利号US201414527044

  • 发明设计人 MATTHIAS MICHAEL MERKENSCHLAGER;

    申请日2014-10-29

  • 分类号A61K35/17;C12N5/0783;

  • 国家 US

  • 入库时间 2022-08-21 15:24:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号